Huber, Adrian Thomas http://orcid.org/0000-0001-6146-8238
Fankhauser, Severin
Wittmer, Severin
Chollet, Laureve
Lam, Anna
Maurhofer, Jens
Madaffari, Antonio
Seiler, Jens
Servatius, Helge
Haeberlin, Andreas
Noti, Fabian
Brugger, Nicolas
von Tengg-Kobligk, Hendrik
Gräni, Christoph
Roten, Laurent
Tanner, Hildegard
Reichlin, Tobias
Funding for this research was provided by:
University of Bern
Article History
Received: 3 October 2023
Revised: 3 October 2023
Accepted: 6 November 2023
First Online: 10 January 2024
Declarations
:
: The scientific guarantor of this publication is Prof Dr. Dr. Adrian Huber.
: Dr. Reichlin has received research grants from the Goldschmidt-Jacobson Foundation, the Swiss National Science Foundation, the Swiss Heart Foundation, and the sitem-insel support fund, all for work outside the submitted study. He has received speaker/consulting honoraria or travel support from Abbott/SJM, Bayer, Biosense-Webster, Biotronik, Boston-Scientific, Daiichi Sankyo, Farapulse, Medtronic, and Pfizer-BMS, all for work outside the submitted study. He has received support for his institution’s fellowship program from Abbott/SJM, Biosense-Webster, Biotronik, Boston-Scientific, and Medtronic for work outside the submitted study.Dr. Huber has received research grants from the Swiss National Science Foundation, the Helmut-Hartweg Foundation, and the Foundation to Fight against Cancer, all for work outside the submitted study. He has received speaker/consulting honoraria or travel support from Bayer, Bracco, and Siemens, all for work outside the submitted study.Dr. Tanner reports educational grants from Biosense-Webster and travel grants from Abbott.Dr. Haeberlin: travel/educational grants from Medtronic and Philips/Spectranetics; co-founder and head of Act-Inno, a cardiovascular device testing company; research grants from the Swiss National Science Foundation, the Swiss Heart Foundation, the Swiss Heart Rhythm Foundation, the Swiss Pacemaker Foundation, the Hasler Foundation, the Velux Foundation, Novartis, and the sitem-insel Support Funds, all for work outside the submitted study; consultant/advisor for DiNAQOR and Biotronik for work outside the submitted study.Dr. Gräni received funding from the Swiss National Science Foundation, InnoSuisse, the Center of Artificial Intelligence University of Bern, and the GMABIT foundation, outside of the submitted work.Dr. Roten received research grants from Medtronic and speaker/consulting honoraria from Abbott and Medtronic.Dr. von Tengg-Kobligk received funding from the Swiss National Science Foundation and InnoSuisse. He has received speaker/consulting honoraria from Mint Medical, all outside of the submitted work.All other authors report no conflicts of interest related to this paper.
: One of the authors (A.T.H.) has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Another study was published based on the same patient population, as we made transparent and cited appropriately (Huber et al, 2022, Radiology, ExternalRef removedExternalRef removed). This other study analyzed the enhancement of the LA EAT between noncontrast and contrast-enhanced scans, while the present study analyzes the LA EAT dispersion solely on contrast-enhanced scans. Therefore, the two studies were different.
: • prospective• diagnostic or prognostic study• performed at one institution